香港股市 將收市,收市時間:2 小時 11 分鐘

CORT Jun 2024 31.000 put

OPR - OPR 延遲價格。貨幣為 USD。
加入追蹤清單
2.70000.0000 (0.00%)
市場開市。 截至 09:58AM EDT。
全螢幕
前收市價2.7000
開市2.0000
買盤0.0000
賣出價0.0000
拍板31.00
到期日2024-06-21
今日波幅2.0000 - 2.7000
合同範圍
成交量2
未平倉合約
  • Insider Monkey

    What Makes Corcept Therapeutics (CORT) a Good Investment Bet?

    ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Value Strategy” first quarter 2024 investor letter. A copy of the letter can be downloaded here. The firm focuses on companies with strong balance sheets and attractive cash flows with compelling valuations rather than following market trends. The strategy outperformed the benchmark Russell 2000 Value […]

  • Zacks

    Corcept Therapeutics (CORT) is a Top-Ranked Momentum Stock: Should You Buy?

    Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

  • Reuters

    Teva sues Corcept over mifepristone 'monopoly' for rare disorder

    Teva Pharmaceuticals sued rival drugmaker Corcept Therapeutics in federal court in San Francisco on Thursday, accusing it of monopolizing the market for mifepristone-based Korlym, used to treat a rare hormonal disorder called Cushing's syndrome. The lawsuit said Corcept and specialty pharmacy Optime Care, the sole distributor of Korlym, orchestrated “a multifaceted scheme to prolong Corcept’s monopoly by stifling competition from Teva at every turn.” Teva accused Corcept of "paying bribes and kickbacks" to physicians to keep them prescribing brand Korlym.